XML 99 R86.htm IDEA: XBRL DOCUMENT v3.24.4
Schedule of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]        
Number of Shares Outstanding, Beginning Balance 99,486 86,951 30,737  
Weighted Average Exercise Price, Beginning Balance $ 39.26 $ 62.16 $ 95.40  
Weighted Average Remaining Contractual Life (in Years), Outstanding 9 years 7 months 24 days 8 years 9 months 14 days 9 years 3 months 7 days 9 years 11 months 8 days
Aggregate Intrinsic Value, Outstanding, Beginning Balance [1] $ 1 $ 1,691  
Number of Shares Outstanding, Granted 1,242,722 49,730 64,572  
Weighted Average Exercise Price, Granted $ 1.38 $ 9.35 $ 48.20  
Number of Shares Outstanding, Exercised  
Weighted Average Exercise Price, Exercised  
Number of Shares Outstanding, Canceled or forfeited (16,764) (37,195) (8,358)  
Weighted Average Exercise Price, Canceled or forfeited $ 14.19 $ 52.55 $ 76.11  
Number of Shares Outstanding, Canceled or forfeited 16,764 37,195 8,358  
Number of Shares Outstanding, Ending Balance 1,325,444 99,486 86,951 30,737
Weighted Average Exercise Price, Ending Balance   $ 39.36    
Aggregate Intrinsic Value, Outstanding, Balance [2] [1] $ 1 [1] $ 1,691 [1]
Number of Shares Execisable, Ending Balance 59,324 27,815    
Weighted Average Exercise Price Options Exercisable, Ending Balance $ 40.76 $ 67.54    
Weighted Average Remaining Contractual Life (in Years), Exercisable 7 years 10 months 13 days 8 years 1 month 20 days    
Aggregate Intrinsic Value, Exercisable, Balance [2] [1]    
Weighted Average Exercise Price, Ending Balance $ 4.04 $ 39.26 $ 62.16 $ 95.40
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of the common stock for the options that were in the money at December 31, 2023 and December 31, 2022.
[2] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of the Common Stock for the options that were in the money at September 30, 2024.